Cellular metabolism constrains innate immune responses in early human ontogeny by Kan, Bernard et al.
ARTICLE
Cellular metabolism constrains innate immune
responses in early human ontogeny
Bernard Kan 1,2, Christina Michalski 1,2, Helen Fu1,2, Hilda H.T. Au 3, Kelsey Lee 1,2,
Elizabeth A. Marchant1,2, Maye F. Cheng1,2, Emily Anderson-Baucum4, Michal Aharoni-Simon1,9, Peter Tilley5,6,
Raghavendra G. Mirmira4, Colin J. Ross 1,7, Dan S. Luciani1,8, Eric Jan 3 & Pascal M. Lavoie 1,2
Pathogen immune responses are profoundly attenuated in fetuses and premature infants, yet
the mechanisms underlying this developmental immaturity remain unclear. Here we show
transcriptomic, metabolic and polysome proﬁling and ﬁnd that monocytes isolated from
infants born early in gestation display perturbations in PPAR-γ-regulated metabolic pathways,
limited glycolytic capacity and reduced ribosomal activity. These metabolic changes are
linked to a lack of translation of most cytokines and of MALT1 signalosome genes essential to
respond to the neonatal pathogen Candida. In contrast, they have little impact on house-
keeping phagocytosis functions. Transcriptome analyses further indicate a role for mTOR and
its putative negative regulator DNA Damage Inducible Transcript 4-Like in regulating these
metabolic constraints. Our results provide a molecular basis for the broad susceptibility to
multiple pathogens in these infants, and suggest that the fetal immune system is metaboli-
cally programmed to avoid energetically costly, dispensable and potentially harmful immune
responses during ontogeny.
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Infection is a leading causes of neonatal mortality worldwide,responsible for over one million deaths each year in infantsunder 28 days of age1. Infants born prematurely are particu-
larly vulnerable to severe infections. Indeed, one out of six pre-
term infants born below 37 weeks of gestation will develop a life-
threatening infection in their ﬁrst month or life, owing to
immaturity of their immune defenses2,3
Candida species (spp.) are a major neonatal pathogen, and
remain an important cause of mortality from sepsis in premature
infants despite a decreasing incidence of candidiasis over the last
decade4. In healthy adults, this micro-organism rarely causes
invasive disease5,6. In contrast, newborns are more vulnerable,
especially those who are born below 33 weeks of gestation4. This
warrants research to understand the molecular basis for their
increased susceptibility to Candida, but also to other neonatal
pathogens7. Prevention of systemic Candida infection in humans
requires immune recognition and phagocytosis via Pattern
Recognition Receptors (PRR)8. PRR-mediated immune responses
are profoundly attenuated during gestation, until about 29 to
33 weeks9,10. Despite the major clinical impact of these functional
deﬁcits, we lack a molecular understanding of how these
responses are regulated during ontogeny.
Candida spp. can exist as yeast or hyphae5. C-type lectins and
Toll-like receptors (TLRs) are the main PRRs involved in the
immune recognition of Candida spp8. Yeast forms are strongly
detected by the C-type lectin receptor dectin-1 and predominate
in the bloodstream during invasion. In contrast, hyphae can also
be recognized via TLR2 and TLR4 in addition to a main role for
C-type lectin receptors11–14. Dectin-1 binds the fungal cell wall
component β-1,3-glucan15,16, resulting in the production of pro-
inﬂammatory cytokines including interleukin-1β (IL-1β). This
cytokine is crucial for rapid innate immune responses17, but also
for the generation of a long-lasting mucosal immunity against
Candida18. At the cellular level, monocytes (in blood) and mac-
rophages (in tissues) are the main source of IL-1β. Dendritic cells
play an important role in presenting fungal antigens to T cells.
However, monocytes demonstrate increased reactivity to Candida
albicans compared to dendritic cells and macrophages, high-
lighting the importance of the former in preventing disseminated
infection through blood19.
Production of IL-1β in monocytes can occur via two main
cellular pathways: In the canonical pathway, activation of PRRs
results in expression of the Il1b gene, which is then translated into
the pro-IL-1β precursor protein until a second danger-associated
signal (e.g., tissue damage) leads to proteolytic cleavage of pro-IL-
1β and secretion of its mature IL-1β form via the NLRP3/Cas-
pase-1 inﬂammasome (reviewed in ref. 8). Alternatively, in the
non-canonical pathway, both the production of pro-IL-1β and its
cleavage into mature IL-1β by caspase-8 occur via activation of
the MALT1/Bcl10/CARD9 signalosome pathway20,21. In humans,
the importance of the signalosome is evidenced by data showing
increased invasive Candida infections in subjects carrying loss-of-
function mutations in CARD922.
Despite decades of research into the functional characterization
of the neonatal immune system, we lack an understanding of the
mechanisms regulating PRR responsiveness during onto-
geny2,3,23. To address this question, we studied responses to
Candida spp., a major neonatal pathogen that is recognized
through multiple PRRs, and for which relatively little is known in
human newborns. Combining transcriptomic, metabolic and
polysome proﬁling studies in an unbiased way, we ﬁnd that
neonatal monocytes are metabolically skewed and lack translation
of key immune response genes in a gestational age-dependent
manner. Our data provide a mechanism whereby the broad
attenuation in PRR responses in early gestation can concurrently
increase vulnerability of preterm infants to multiple neonatal
pathogens. In light of these results, we propose that preterm
immune cells are metabolically reprogrammed to avoid innate
immune activation signals in early ontogeny, at the same time
offering potential therapeutic avenues to restore immune deﬁcits
and reduce infections in these high-risk infants.
Results
Lack of anti-fungal immune recognition in early gestation. To
examine responses to Candida species, we ﬁrst compared
monocytes’ ability to phagocytose clinical strains of this micro-
organism between preterm, term neonatal and adult subjects.
Notably, preterm cells phagocytosed Candida albicans as well as
adults (Fig. 1a). On the other hand, mononuclear cells from
preterm neonates were unable to produce a cytokine response in
presence of Candida albicans or C. parapsilosis, as demonstrated
by a lack of production of IL-1β, IL-6 (Fig. 1b, c) and of other
cytokines (Supplementary Figure 1). When assaying speciﬁc
receptors, preterm neonatal cells also did not respond to dectin-1
(using curdlan), TLR2 (using zymosan) or TLR4 (using LPS)
stimulation (Fig. 1d-g) despite a strong response detected in adult
and term neonatal cells. At the transcript level, responses to LPS
were generally stronger then responses to curdlan across all three
age groups (Supplementary Figure 2). However, cytokine gene
responses to curdlan were reduced in preterm subjects, suggesting
an upstream dectin-1 signaling deﬁcit in the latter age group
(Supplementary Figure 2).
The importance of dectin-1 for recognition of Candida was
conﬁrmed by efﬁcient blocking of cytokine responses using a
neutralizing receptor antibody (Fig. 2a). On the other hand,
dectin-1 blocking only partially inhibited phagocytosis of this
pathogen (Fig. 2b). Moreover, phagocytosis of Candida was
unaffected by blocking other receptors known to be important for
the uptake of this micro-organism (Fig. 2c, d), which is consistent
with a functional redundancy of these receptors8. Altogether, our
data suggest a functional impairment in the PRR mediating the
immune recognition of Candida in preterm monocytes, thereby
abrogating cytokine responses, but not phagocytosis of this
pathogen.
Broad metabolic impairments in preterm monocytes. The lack
of cytokine response to Candida in preterm cells was concerning
given the major importance of this pathogen mediating invasive
disease in these infants. Yet, the molecular basis for this vulner-
ability is unknown. To investigate this, we used an unbiased,
systems approach comparing the transcriptome of adult, term
and preterm monocytes, at the genome-wide level. First, a gene
ontology analysis comparing the transcriptome of unstimulated
preterm, term neonatal and adult monocytes revealed major
differences located mainly in pathways involved in glycolysis,
oxidative phosphorylation and beta-oxidation metabolism
(Fig. 3a–c; Supplementary Figure 3; Supplementary Figure 4).
Notably, differences were seen also with a profound
downregulation of ribosomal genes (Fig. 3d) and an
over-representation of down-regulated genes involved in trans-
lation initiation (adjusted p= 8.3 × 10−21), translation (adj. p=
2.6 × 10−07), and cell activation pathways (adj. p= 2.6 × 10-16;
Supplementary Data 1).
In light of the reduced responses to curdlan in preterm cells, we
opted to compare gene expression responses to LPS instead.
Upon stimulation with LPS, a large proportion of genes (∼40%)
were comparatively upregulated in all 3 age groups (Fig. 4a, b),
including strong gene expression of Il1b, Tnfa, and Il6 (Fig. 4c), as
well as other cytokine/chemokine genes (Supplementary Figure 5).
In independent qPCR experiments, expression of the IL1b and
IL6 cytokine genes was detectable after 30 min, and followed a
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similar kinetics, peaking between 5 and 8 h in all three age groups
(Jen R, Sharma A, and Lavoie PM, unpublished data and ref. 24).
Strikingly, however, the strong gene expression response in
preterm cells contrasted with the lack of corresponding protein
expression (Fig. 4d), particularly for IL-1α/β, TNF-α, and IL-10,
suggesting a translation defect. Of note, the same changes in
metabolic and ribosomal-related genes persisted in LPS-
stimulated cells (Supplementary Data 2).
Defective immune response translation in preterm monocytes.
To assess whether preterm monocytes lacked translation of
immune response genes, we performed polysome analysis.
Monocyte lysates from all three age groups were subjected to
sucrose gradient fractionation; the concentration of speciﬁc
mRNAs in monosome, disome, and light and heavy polysome
fractions were measured by RT-qPCR. This experiment was
extremely difﬁcult due to the limited number of monocytes
obtainable from preterm infants. Given the lack of dectin-1
response, we focused on interrogating this pathway (Fig. 5a).
Despite the technical challenge, we were able to perform
polysome proﬁling in all three age groups (Fig. 5b). In general, the
overall distribution of mRNAs across the polysome gradient was
similar between preterm, term and adult samples, but distinct
between genes, suggesting that each mRNA is translated with
different intensity (Fig. 5c). Expression of the Malt1, Bcl10, and
Card9 genes in total mRNA fractions were comparable between
all three age groups (Fig. 5d). In the polysome fractions, Actb,
Clec7a, and Card9mRNAs, which respectively encode β-actin, the
dectin-1 receptor, and Caspase recruitment domain-containing
protein 9 (CARD9), were present in heavy polysomes in preterm
monocytes. This is similar to the distribution in term and adult
monocytes, indicating that these mRNAs are translated even at
low gestational age. In contrast, the majority of Bcl10 and Malt1
mRNAs was associated with monosomes and disomes in preterm
and adult monocytes, and only Malt1 mRNA was detected in
heavy polysomes, in term monocytes (Fig. 5c). These results
potentially indicate that dectin-1 signaling genes are differentially
translated across the gestational age spectrum.
Next, we asked whether these proteins were expressed in
monocytes from all three age groups. The dectin-1 protein was
comparably expressed between preterm, term, and adult mono-
cytes (Fig. 5e). In contrast, expression of the MALT1 protein, but
also the Syk and CARD9 proteins, were severely reduced in
preterm monocytes (Fig. 5f, g; Supplementary Figure 6). For
Bcl10 protein, expression was undetectable in preterm monocytes
by Western blotting (Fig. 5f, h). To conﬁrm whether translation
was reduced in preterm cells, pulse-labeling experiments were
conducted and showed reduced 35S-methionine/cysteine incor-
poration in the latter, in response to LPS (Supplementary
Figure 7).
Role of MALT1 in the monocyte response against Candida spp.
The role of the MALT1 signalosome in dectin-1 responses in
myeloid cells has been mainly studied in mice macrophages and
dendritic cells, but it has not been formally established in human
monocytes20,25. Moreover, due to the major role of MALT1 in T
and B cells activation, it is also unclear whether signaling through
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Fig. 1 Responses to Candida spp. in neonatal immune cells. a Phagocytosis of Candida in monocytes (boxes and whiskers), including a representative ﬂow
microscopy diagram (white bar=∼10 µm). Data pooled from multiple experiments over 14 months (9 to 17 subjects per age group; see Supplemental Data
for clinical information on preterm subjects); b IL-1β and c IL-6 response (blood mononuclear cells) to C. albicans or C. parapsilosis (24 h stimulation; 10 to
18 subjects per age group; boxes and whiskers); (d) IL-1β (24 h; 11 to 21 subjects per age group; boxes and whiskers) and e representative gating for pro-IL-
1β (5 h LPS stimulation), gated on CD14-expressing cells (black= ﬂuorescent-minus one control; orange= unstimulated; blue= LPS; representative
preterm sample is from a 26 weeks’ infant); f pro-IL-1β (5 h) or g IL-6 (24 h) in response to LPS, zymosan or curdlan (mononuclear cells; 11 to 21 subjects
per age group; boxes and whiskers); for b and c, data was pooled from multiple experiments assayed in four ELISA batches with similar distribution of
samples per age group
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this molecule is also essential for myeloid responses to Candida in
humans26.
To conﬁrm this, we examined the effect of blocking MALT1 on
both cytokine responses and phagocytosis of Candida species, in
human monocytes. Complete loss of cytokine response to curdlan
was observed with MALT1 inhibition (Fig. 6a). When testing
responses to clinical strains of Candida, MALT1 blocking also
completely abrogated cytokine responses to C. albicans or C.
parapsilosis (Fig. 6b–d). Blocking of Syk also partially abrogated
responses to these two micro-organisms, indicating that the
response to Candida primarily involves signaling through dectin-
1 (Fig. 6b–d). On the other hand, these responses were neither
affected by blocking of MyD88 (downstream of TLRs) nor Raf-1
(mediating MALT-1-independent dectin-1 signaling; Fig. 6b–d).
Given that preterm monocytes are fully able to phagocytose
Candida, we also examined the role of MALT1 in this function.
MALT1 inhibition did not block uptake of Candida spp.,
indicating a non-essential role in phagocytosis (Fig. 6e). Alto-
gether, these results conﬁrm an essential role of the
MALT1 signalosome in the recognition, but not the phagocytosis
of whole Candida in human monocytes.
Altered energy metabolism in preterm monocytes. Recent data
has demonstrated that a shift in basic cellular energy metabolism
from oxidative phosphorylation to glycolysis is required during
immune cell activation, in order to provide the rapid energy and
metabolic intermediates necessary for translation of immune
response proteins27. While these studies have been mainly con-
ducted in macrophages and dendritic cells, we conﬁrmed the
importance of this mechanism also in human monocytes by
showing inhibition of cytokine production with 2-DG, a non-
functional glucose analog that inhibits glycolysis (Fig. 7a).
In light of the reduced translation in preterm monocytes, we
asked whether glycolysis could be impaired. To this end, we
compared the glycolytic capacity of preterm, term, and adult
monocytes. Notably, glycolysis was severely diminished in
preterm monocytes (Fig. 7b, c). The reduced glycolytic activity
in preterm monocytes was also reﬂected in reduced lactate
production (Fig. 7d) and reduced glucose uptake (Supplementary
Figure 8), at lower gestation, upon LPS but also at rest (in
unstimulated cells). In term monocytes, glycolysis was variably
affected, suggesting a transitional functional state.
Given that phagocytosis is preserved in preterm cells, these
data raise an important question: do these metabolic constraints
differ between cytokine responses and phagocytosis? Indeed, the
requirement for glycolysis and/or translation has been mainly
studied for PRR-mediated cytokine responses27, but only sparsely
for phagocytosis28,29. Consequently, we showed that phagocytosis
of Candida was unaffected by blocking glycolysis, or even by
blocking of de novo protein synthesis (Fig. 7e). These results
indicate a speciﬁc requirement of glycolysis for PRR-mediated
responses, but not for phagocytosis.
Human adult monocytes are capable of rewiring their
metabolism to adapt their energy requirements in a function-
speciﬁc manner29. The nuclear receptor PPAR-γ plays an
important role in this function, regulating lipid uptake. PPAR-γ
has also been shown to regulate phagocytosis in addition to
promoting anti-inﬂammatory responses in human mono-
cytes30,31. In preterm monocytes, we observed a net down-
regulation of mitochondrial electron transport (Supplementary
Figure 9) and oxidative phosphorylation transcripts (Supplemen-
tary Figure 10A). Corresponding measures of oxygen consump-
tion rates in preterm monocytes suggested decreased ATP-linked
respiration (Supplementary Figure 10B), consistent with a
metabolically quiescent state. Interestingly, expression of PPAR-
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Fig. 2 Importance of dectin-1 in response to Candida in neonatal monocytes. a Antibody blocking of dectin-1 reduces cytokine production to C. albicans (Ca)
in adult mononuclear cells (one-sided t-test with Welch’s correction for unequal variance; 6 to 12 subjects per condition; boxes and whiskers); b
Phagocytosis of C. albicans upon blocking with anti-dectin-1 receptor antibody, same-isotype control or cytochalasin-D (Cyto-D); (11 to 18 subjects per age
group; boxes and whiskers); Blocking of c C. albicans (Ca) or d C. parapsilosis (Cp) phagocytosis using laminarin (blocking dectin-1), mannan (blocking
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deviation (SD); 2 to 3 subjects per age group)
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γ was increased in preterm monocytes (Supplementary Fig-
ure 10A). Furthermore, increased PPAR-γ activity in preterm
monocytes is supported also by upregulation of its target genes
mapping to metabolic pathways (Supplementary Figure 11).
Altogether, these data indicated a rewiring of metabolic pathways
favoring phagocytosis instead of pathogen-mediated pro-inﬂam-
matory cytokine responses, in preterm monocytes.
Developmental regulation through mTOR. The data above raise
an additional important question: how are glycolysis and
a
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translation negatively regulated in preterm monocytes. Mechan-
istic target of Rapamycin (mTOR) is a key regulator of the
metabolic switch towards glycolysis during immune activation
(depicted in Fig. 7f)32. Therefore, we examined the mTOR reg-
ulator node developmentally. Interestingly, preterm monocytes
showed reduced phosphorylation of mTOR following LPS sti-
mulation (Fig. 7g). These cells also displayed reduced expression
of its main downstream target 4EBP1, which is important in
mediating the effect of mTOR on translation downstream of PRR
activation (Fig. 7g). Given the difﬁculty in getting sufﬁcient
amounts of monocytes for efﬁcient detection of mTOR phos-
phorylation by Western blot in preterm cells, we employed a ﬂow
cytometry assay, on a larger number of subjects. Using this
approach, we conﬁrmed the reduced mTOR phosphorylation, but
also the gestational age-dependent functional dissociation
between mTOR phosphorylation and cytokine responses in pre-
term monocytes (Supplementary Figure 12).
Next, we more closely examined regulatory gene expression
within the mTOR pathway. Again, due to the absence of dectin-1/
MALT1 signaling, we focused our analyses on LPS-stimulated
cells. Major differences were observed in neonatal monocytes in
the mTOR pathway (Supplementary Data 3), including a
decreased expression of the upstream mTOR activator RAC-
alpha serine/threonine-protein kinase (encoded by the Akt1
gene). Expression of the insulin receptor substrate 2 (Irs2) gene,
which is an upstream regulator of mTOR, the genes encoding the
adenosine monophosphate-activated protein kinase (prkaa2) and
the hypoxia-inducible factor 1-alpha (Hif1a) were increased in
a
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preterm monocytes compared to term or adults especially after
LPS stimulation, which may represent compensatory
mechanisms.
Most notably, expression of the negative mTOR regulators
NAD-dependent deacetylase sirtuin-1 (Sirt1) and DNA damage
inducible transcript-4-like (Ddit4l) were profoundly upregulated
in preterm monocytes. Ddit4l is a paralog of the DNA damage
inducible transcript-4 (Ddit4) that has also been shown to inhibit
mTOR33,34 (Fig. 7h). Upregulation of Ddit4l was further
conﬁrmed at the protein level in neonatal preterm monocytes
by Western blot (Supplementary Figure 13), suggesting that this
molecule may represent an important developmental-speciﬁc
negative mTOR regulator.
Glycolysis is required for MALT1 protein expression. The
experiments described above reveal two main deﬁcits in preterm
monocytes: (i) a lack of dectin-1 signaling resulting in a lack of
cytokine responses to Candida, and (ii) a reduced metabolic state
leading to reduced innate immune responsiveness to LPS acti-
vation. In order to investigate whether these two functional def-
icits are linked, we tested whether blocking of glycolysis impaired
translation of MALT1. In both Western blot and ﬂow cytometry
analyses, MALT1 protein levels were signiﬁcantly reduced after 2-
DG treatment (Fig. 8a–c). In contrast, protein expression of β-
actin, a highly abundant gene transcript (see above) was unaf-
fected (Fig. 8a). Conversely, inhibition of MALT1 did not affect
the glycolytic capacity of these cells, as shown by sustained lactate
levels both at rest and after LPS (Fig. 8e). In the latter experiment,
LPS-induced cytokine responses correlated with lactate levels
(Fig. 8f). Together these data are consistent with reduced glyco-
lysis limiting cytokine responses and MALT1 protein expression
in preterm cells rather than the other way around.
Immune response and risk of invasive Candida infection.
Finally, we sought to determine how reduced cytokine responses
in preterm cells may impact infants’ risk of invasive infections. In
order to assess this, we reviewed data from 39,336 infants born
below 33 weeks of gestation in Canada over 10 years. We found
that rates of invasive infections exponentially increased with
decreasing gestational age (Supplementary Table 1). When spe-
ciﬁcally looking at Candida infections, rates of candidemia also
increased exponentially at lower gestation (Supplementary
Table 1). Rates of invasive Candida infections also inversely
correlated with in vitro responses to this pathogen (Supplemen-
tary Figure 14). Altogether, our data provide further evidence that
the increased risk of invasive infections in these infants may be
related to a lack of immune responses to Candida species.
Discussion
Infection and prematurity are thought to kill more newborns than
any other cause globally (about one million infants die from
infections each year)35. Despite this, we lack insights into the very
basic mechanisms responsible for the high immunological vul-
nerability of preterm neonates, which restrain innovation towards
new therapeutic interventions. In this study, we provide the ﬁrst
evidence of a role for cellular energy metabolism regulating
neonatal innate immune responsiveness during ontogeny, in a
gestational age-dependent manner. We also provide insights into
how this may occur, through a lack of expression of key immune
response proteins in the context of reduced glycolytic metabolic
capacity. Our data suggest that multiple PRR responses could be
broadly affected through these mechanisms in preterm myeloid
cells. In light of our data, we posit that constraining innate
immune reactivity in utero during development is physiologically
important, possibly to limit adaptive immune co-activation sig-
nals during the early establishment of self-tolerance, but also to
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avoid energetically costly immune responses early in gestation.
Indeed, translation consumes up to ∼45% of cellular ATP36.
Immune activation triggers an upregulation of glycolytic path-
ways to rapidly supply the high energy needs and metabolic
intermediates required for protein synthesis37. Preventing an
invasive Candida infection is also relatively costly energetically28,
and may not be speciﬁcally advantageous prior to a viable fetal
stage. On the other hand, the preservation of other immune
functions such as phagocytosis may be more essential and is in
keeping with previous studies29,38,39. This may stem from a more
essential need for house-keeping tissue remodeling functions
during fetal development40.
Our results raise important mechanistic questions. For
instance, it is unclear how translation is selectively impaired by
the metabolic constraints observed in preterm monocytes. Intri-
guingly, transcripts that were less abundant (by qPCR) also
showed less protein expression, consistent with a limited ribo-
somal activity in preterm cells. We hypothesize that the reduced
ribosomal activity in preterm cells may selectively impair the
translation of immune response genes that are more scarcely
abundant, as suggested in our polysome experiments. On the
other hand, abundant transcript may still be efﬁciently translated,
allowing to maintain cell viability. Upon activation of immune
cells, it is also possible that immune response genes are selectively
not translated through sequence-speciﬁc mechanisms. Supporting
this model, 5’-terminal oligopyrimidine tract (TOP)-containing
mRNAs such as those encoding ribosomal proteins and transla-
tion factors, and mRNAs with short 5’UTRs have been shown to
be more sensitive to mTOR activity41–43. In such cases the
availability of eIF4F complexes (via regulating 4E-BP) may spe-
ciﬁcally limit the synthesis of those proteins41–43. In preterm cells,
it is also possible that under reduced mTOR activity, the rate of
translation of immune response proteins may be less than the rate
of their turn-over due to cis-acting elements in their 5’UTRs.
Consistent with this model, pharmacological inhibition of mTOR
using PP242, reduced translation of MALT143. The precise
mechanisms that limit expression of immune proteins in preterm
cells require future studies.
Our data shed additional light on the roles of MALT1 in the
response of myeloid cells to Candida spp. in humans. Previous
studies have been conducted in murine dendritic cells where
blocking of MALT1 using siRNA or using a knock-out in mice
abrogates cytokine responses to multiple strains of Candida spp.
as well as to curdlan20,25. In humans, the role for MALT1 in
protecting against invasive Candida infections has been obscured
by the major importance of MALT1 in T cells and B cells26. Our
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work conﬁrms a central role for MALT1 in the immune recog-
nition of Candida also in human myeloid cells. Moreover, our
data suggest that the loss of MALT1 function in preterm cells
impairs the ability to respond to Candida spp., although the
extent to which impaired translation of additional immune
response genes limit other immune pathways remains to be
determined. Of note, our observation that Candida responses
were partially abrogated by blocking Syk may suggest the exis-
tence of a Syk-independent, yet unidentiﬁed, non-dectin receptor
that activates responses via MALT1.
Our data have potential clinical relevance. While a mechanism
that limits innate immune responsiveness during fetal develop-
ment may be essential to protect against organ damage in utero44,
it becomes a serious problem when a preterm birth occurs, due to
increased infections in the premature infant. One key question is:
can these constraints be reversed therapeutically, and if so, how?
The comparably strong transcriptomic response in preterm
monocytes is not unique to LPS, and has been reported with
whole bacterial micro-organisms (Escherichia coli and Staphylo-
coccus epidermidis)45. Monocytes from adult subjects after an
endotoxin challenge or sepsis also display a similar transcriptome
proﬁle46. In this latter case, immune training using low dose
stimulation through the dectin-1 receptor could reverse the
metabolic constraints46, though the absence of dectin-1 signaling
in preterm cells likely precludes this approach47. Alternatively,
metabolic constraints may also be reversed with pre-treatment of
cells with IFN-γ46,48–50. Interestingly, clinical trials suggest that
IFN-γ treatment may ameliorate clinical outcomes in adults post
sepsis51,52. Newborn immune cells produce reduced IFN-γ,
especially in absence of exogenous polarization53. One study
showed that preterm whole blood pre-treated with IFN-γ show
augmented immune responsiveness to LPS in vitro, thus repre-
senting a potential therapeutic avenue that could be explored to
restore immune defenses after birth54. Alternatively, SIRT1
inhibitors have also been shown in pre-clinical trials to augment
glycolysis and immune responses post sepsis, through a stabili-
zation of HIF-1α55. Despite the multiple challenges that lie
between our studies and a potential therapeutic application in
preterm infants, our studies represent an important discovery and
reveal potential translational research avenues to tackle the high
vulnerability of these infants to infections. However contrary to
adults, our data suggest that the lack of glycolytic and mTOR
activity in preterm cells may be actively suppressed, possibly
through the putative mTOR regulator DDIT4L. In this context,
further studies are required to determine how a metabolic
reprogramming of preterm myeloid cells can be sustainably
achieved at the cellular level.
A limitation of our study is the strict use of cord blood which
may not adequately represent peripheral blood immune responses
during the neonatal period. However, obtaining sufﬁcient volumes
of peripheral blood from premature neonates is ethical question-
able and could not be achieved for safety reasons. Indeed, only a
handful of studies have measured immune parameters in per-
ipheral blood from premature neonates, and these studies conﬁrm
the marked attenuation in PRR responses compared to term
neonates, with correlation of the expression of phagocytosis and
monocyte activation marker between cord and peripheral
blood38,56–60. Therefore, it appears that cord blood is a reason-
able alternative to using peripheral blood, though important dif-
ferences exist and the former does not reﬂect the dynamic changes
occurring over time when infants are most susceptible to sep-
sis56,60. A second limitation is the focus on monocytes, which
incompletely recapitulates the complex cell-microbes interactions
during sepsis in vivo. For example, IL-1β can be cleaved by serine
proteases (e.g., PR3, cathepsin G) expressed by neutrophils, in
addition to caspases. Because of the crucial role of neutrophils in
preventing Candida invasion in humans8, speciﬁc studies are
required to determine the contributions of other immune cells.
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In summary, our data reveal important metabolic constraints
that limit immune activation against major neonatal pathogens in
monocytes before the term of gestation. This mechanism provides
a unifying pathway to explain the broadly suppressed innate
immune responsiveness during human fetal development. Future
studies are required to understand how reduced mTOR function
impairs translation in preterm monocytes, and how the putative
negative regulator of mTOR, DDIT4L may regulate this pro-
cess34. Finally, the availability of metabolic reprogramming drugs
in pre-clinical studies may offer therapeutic avenues to augment
immune reactivity and reduce the major burden from infections
in these high-risk preterm newborns55.
Methods
Human subjects. This study was conducted according to the Canadian Tri-
Council Policy Statement: Ethical Conduct for Research Involving Humans at http://
www.pre.ethics.gc.ca/eng/policy-politique/initiatives/tcps2-eptc2/Default/. Cord
blood was obtained from preterm infants (<33 weeks) and term infants (>38
to<41 weeks) born by elective cesarean section in absence of labor, and peripheral
blood was obtained from healthy adult volunteers recruited at the BC Children’s
Hospital Research Institute. All blood samples were collected in sodium heparin
vacutainers. Cord blood from more than 104 preterm deliveries were used in the
experiments included here. To assess whether the lack of dectin-1 response in
preterm subjects may have been due to an enrichment of loss-of-function genetic
variants in the dectin-1 receptor, genotyping for the common Y238X mutation
(SNP rs16910526) was performed on a previous cohort of infants born before
31 weeks of gestation61. Only 2 out of the 177 infants were homozygous for the rare
variant, a rate similar to the adult population62.
The clinical characteristics of the preterm subjects included in each of the
ﬁgures are provided in aggregated form, in the accompanying Supplementary
Tables 2 to 14. All cord blood samples were collected following delayed cord
clamping clinical standards, and after the placenta was detached from the infant.
Written consent was obtained from all participants, except for eight preterm cases
where parents were unavailable/non-reachable in person or by phone. In these
cases, no clinical data was obtained on completely de-identiﬁed cord blood
samples, in accordance with the University of British Columbia Children’s &
Women’s Research Ethics Board (C&W REB). The study complied with all relevant
ethical regulations and was approved by the C&W REB (#H07-01698).
Cells. Mononuclear cells (MNCs) were isolated from between 0.5 and 20 mL of
whole blood (depending on each ensuing experiment) by density centrifugation
using Lymphoprep™ (STEMCELL Technologies). Monocytes were puriﬁed from
MNCs generally from at least 1 mL of whole blood, using an EasySep™ positive
CD14 selection kit (STEMCELL Technologies, #18058) and 1 mM EDTA to pre-
vent cell clumping. Monocyte purity was regularly determined by ﬂow cytometry
(FSC/SSC plus staining for CD14 surface expression) throughout the study, and
strictly conﬁrmed to be > 95% for example, for microarray studies.
Reagents. Pediatric clinical isolates of Candida albicans and Candida parapsilosis,
identiﬁed by mass spectrometry (Bruker Daltonics, Billerica, MA) were obtained
from the BC Children’s Hospital Microbiology Lab (Vancouver, Canada). We used
ﬁxed Candida spp. yeast particles which are closer antigenically to yeast forms5.
Fungi were grown over 4 days at 30 °C in BHI (Brain-Heart Infusion) broth
(Oxoid, Nepean, ON). Yeast in exponential growth phase were harvested after
4 days, centrifuged and ﬁxed in 10% paraformaldehyde. To ensure reproducibility,
batches of Candida particles were prepared and used throughout the study. Human
dectin-1 and dectin-2 neutralizing antibodies were purchased from R&D Systems
(#MAB1859) and Invivogen (#Mabg-hdect2), respectively, and used at 5 µg ml-1 for
cytokine studies, and 10 µg ml-1 for phagocytosis assays. Human CD-206 neu-
tralizing antibody was purchased from Biolegend (#321111) and used at 10 µg ml-1
for phagocytosis assays. Human DC-SIGN neutralizing antibody was purchased
from Invivogen (#mab-hdcsg) and used at 10 µg ml-1 for phagocytosis assays.
Curdlan (β-1, 3-glucan from Alcaligenes faecalis), a dectin-1-speciﬁc agonist, was
obtained from Wako (#032-09902) and used at 10 µg ml-1 in cytokine studies.
Lipopolysaccharide (LPS), a TLR-4 agonist puriﬁed from Escherichia coli, was
obtained from InvivoGen (#tlrl-eblps) and used at 10 ng ml-1. Zymosan, a TLR-2/
dectin-1 agonist was obtained from Invivogen (#tlrl-zyn) and used at 10 µg ml-1.
Mannan was purchased from Sigma-Aldrich (#M3640-1G), and used at 3 mgml-1
in phagocytosis assays. Laminarin was purchased from Sigma-Aldrich (#L9634-
500mg), and used at 5 µg ml-1 in phagocytosis assays. The following anti-target
antibodies were used for Western blots (source): Syk (Abcam, #Ab155187),
MALT1 (Cell Signaling Tech., #2494 S), BCL10 (Cell Signaling Tech., #4237 S),
CARD9 (Abcam, #Ab133560), phospho-mTOR (Cell Signaling Tech., #5536 P),
mTOR (Cell Signaling Tech., #4517 S), 4EBP1 (Cell Signaling Tech., #9644 P), β-
actin (Abcam, #Ab75186), goat anti-mouse (LI-COR Odyssey, #926-68070) and
anti-rabbit antibodies (#926-32213). Primary antibodies were used at a 1:1000
dilution and secondary antibodies were used at a 1:10000 dilution. For MALT1
protein detection by ﬂow cytometry, we used a Phycoerythrin-labeled anti-MALT1
antibody at a 1:100 dilution [EP603Y] (Abcam, #Ab210982). Cell viability was
measured using a Fixable Viability Dye eFluor™ 780 (eBioscience; #65-0865-14;
1:100 dilution). An example of gating strategy for MALT1 detection by ﬂow
cytometry is provided in Supplementary Figure 15.
Cytokine stimulation. MNCs or monocytes were cultured in RPMI 1640 (Roswell
Park Memorial Institute medium) supplemented with 2mM L-glutamine (Gibco,
#25030), 10% human AB serum (Gibco #11875-093) and Pen-strep (Gibco, #15140-
122) (referred to as complete RPMI medium, or cRPMI). MNCs were stimulated in
round-bottomed 96-well plate (Corning Life Sciences, #3799) with ﬁxed Candida
(multiplicity of infection, MOI= 5), LPS (10 ngml-1), Curdlan (10 µgml-1) or
Zymosan (10 µgml-1) for 24 h unless otherwise speciﬁed. For enzyme-linked
immunosorbent assays, supernatants stored at -80 °C were analyzed in batches for IL-
1β and IL-6 (eBioscience, #88-7261-76), or using a multiplex ELISA assay for IL-1α,
IL-1β, IL-1RA, IL-6, TNF-α, and IL-10 (R&D Systems) as per manufacturer’s
instructions. For blocking experiments, MNCs were pre-incubated for 1 h at 37 °C
with neutralizing anti-dectin-1 or anti-dectin-2 antibodies, mepazine hydrochloride
(10 µM, EMD Millipore #5005000001), cycloheximide (100 μgml-1, Sigma-Aldrich
#C4859), ST 2825 (a MyD88 inhibitor, 10 µM, AdooQ Bioscience, #A15248-1),
GW5074 (a Raf-1 inhibitor, 1 µM, Cayman Chemical #10010368-1), Piceatannol (a
Syk inhibitor, 20 µM, Cayman Chemical, #10009355-5).
Flow cytometry. MNCs were washed in PBS (3×) and stained for surface CD14
(eBioscience #25-0149; 1:100 dilution), and dectin-1 (AbD Serotec, #MCA4661A488;
1:100 dilution) as indicated. Intracellular cytokine staining for pro-IL-1β was per-
formed by ﬁxing/permeabilizing cells with Foxp3 Staining Buffer (eBioscience,
#005523-00), and staining with an anti-IL-1β antibody (BioLegend, #508208, 1:50
dilution). After 30min of incubation, cells were washed 3 times in PBS before ana-
lyses. Native mTOR expression and phosphorylation was performed on cryopreserved
mononuclear cells, in batches in order to reduce variability. In brief, MNCs were
thawed, washed in cRPMI (3×) and rested for 1 h. An equal number of cells was
stimulated with LPS for 30min. CD14 antibody (eBioscience, #48-0149-42, 1:100
dilution) was added during the last 15min of incubation. Incubation was stopped and
cells were stained intracellularly using Transcription Factor Phospho Buffer Set (BD
Biosciences, #565575) for native (Cell Signaling Technology, #5043 S, 1:50 dilution)
and phospho-mTOR (Ser2448, Thermo Fisher Scientiﬁc, #501123458, 1:50 dilution).
Cells were washed 3 times in PBS before acquisition on a BD LSRII ﬂow cytometer
(Becton Dickinson). Live cells were gated on singlets. Data were analyzed using
FlowJo v10 (FlowJo, LLC, Ashling OR). CD14-expressing monocytes were identiﬁed
from live cells based on FMO. Cells were analyzed on a BD Fortessa or a 4-laser
customized LSRII ﬂow cytometer (Becton Dickinson). Data were analyzed using
FlowJo v10 (FlowJo, LLC, Ashling OR).
Phagocytosis assay. MNCs were incubated in 96-well plates in the presence of
Candida strains pre-stained for 15 min with DAPI (Biolegend, #422801) at room
temperature. After a 1-h incubation with Candida species, cells were quenched in
Trypan Blue/PBS of any residual ﬂuorescence of non-phagocytized Candida spp,
and then washed once in PBS before staining with a CD14 PE-Cy7-conjugated
antibody (eBioscience, #25-0149, 1:100 dilution). Cells treated with cytochalasin-D
(10 µg ml-1, Sigma-Aldrich) were used as negative controls. Samples were analyzed
on an Amnis Image Stream Imager. Results are presented as the percentage of
monocytes (CD14-expressing cells) that have phagocytosed at least one Candida
particle. Data was analyzed using IDEAS software (v.5.0.343.0)
Western blots. After stimulation (LPS or curdlan), monocytes were washed, and
then lysed in RIPA buffer in presence of phosphatase/protease inhibitors (Santa
Cruz Biotechnology, #sc-24948). Protein quantiﬁcation was performed using a
Pierce 660 nm protein assay (Thermo Fisher Scientiﬁc). Lysates boiled in 4X
Laemmeli buffer (Bio-Rad) supplemented with 2-mercaptoethanol were ran on
4–20% mini-PROTEAN TGX gradient gels (Bio-Rad), transferred to PVDF
membranes, and incubated with primary and secondary antibodies. Blots were
imaged on a LI-COR Odyssey 9120. Images were acquired using Studio ver. 5.2 and
adjusted for brightness. Uncut Western blot images are provided in Supplementary
Figures 16 to 19.
Polysome proﬁling. For polysome proﬁling experiments, a minimum of 3 × 106
monocytes (corresponding to at least 5 mL of cord blood) were pre-cultured with
cycloheximide (100 μg ml-1) for 10 min at 37 °C, washed once in PBS/cyclohex-
imide and lysed in polysome lysis buffer (Mammalian ARTseq™ Ribosome Proﬁling
Kit, Illumina, #RPHMR12126). Lysates were layered onto 10 to 50% sucrose gra-
dients in buffer (0.3 M NaCl, 15 mM Tris-Cl pH 7.5, 15 mM MgCl2, 0.1 mg ml-1
cycloheximide) in the presence of heparin (1 mgml-1) and spun in an ultra-
centrifuge (SW41, Beckman Coulter) for 3.5 h at 4 °C (35,000 rpm) in order to
separate RNA strands based upon ribosomal occupancy. After fractionation, the
puriﬁed, in vitro transcribed dsRED RNA was proportionally spiked into pooled
monosome, disome, or heavy or light polysome fractions as internal control. The
primer sequences used are presented in Supplementary Table 15.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-07215-9
10 NATURE COMMUNICATIONS |          (2018) 9:4822 | DOI: 10.1038/s41467-018-07215-9 | www.nature.com/naturecommunications
Real-time qPCR. Total RNA was isolated using TRIzol LS (Thermo Fisher Sci-
entiﬁc) followed by chloroform extraction and cleaned using RNeasy Mini spin
columns (Qiagen) followed by ethanol precipitation. mRNA was reverse tran-
scribed using SuperScript® III First-Strand Synthesis SuperMix (Thermo Fisher
Scientiﬁc, #18080400), and qPCR experiments were carried out in triplicates on a
ViiA 7 system (Applied Biosystems) using both Power SYBR® Green (Thermo
Fisher Scientiﬁc, #4368706) or TaqMan. Data were normalized on dsRED (ΔCt
method) as detailed in63. Brieﬂy, ΔCt was calculated for each fraction against
dsRED. 2-ΔCt was then calculated, and the sum of all fractions determined. Gene
expression (mRNA) was expressed as (2-ΔCt × 100)/sum of each fraction.
Pulse-labeling experiments. Monocytes were stimulated for 2.5 h and pulsed with
35S-methionine/cysteine for the last 30 min of the experiment. Cells were washed
with PBS and lysed in RIPA (Santa Cruz Biotechnology); equivalent amounts of
protein were loaded on polyacrylamide gel. Blots were imaged on ﬁlm.
Metabolic assays. Glucose uptake in monocytes was measured by ﬂow cytometry.
Cryopreserved MNCs were rested for 1 h at 37 °C in cRPMI after gentle thawing,
and then counted before stimulation for 2 h and 40 min in presence of LPS (10 ng
ml-1), with 2-(N-[7-Nitrobenz-2-oxa-1,3-diazol-4-yl]Amino)-2-Deoxyglucose (2-
NBDG, 15 μM) added for the last 40 min. Cells were stained with CD14
(eBioscience #25-0149; 1:100 dilution) and CD16 (eBioscience #48-0168; 1:100
dilution) at the beginning of LPS stimulation. Cells were washed twice before
acquisition on a LSRFortessa™ ﬂow cytometer (Becton Dickinson). Data was ana-
lyzed using FlowJo® (FlowJo, LLC). For extracellular ﬂux analyses, monocytes were
plated on Cell-Tak™ (Corning, #354240)-coated XF96 Cell Culture Microplates.
Cells were rested in a non-CO2 incubator, and glycolysis stress test was performed
as per manufacturer protocol (Agilent Seahorse, #103020-100) using the Seahorse
XFe96 Analyzer. Extracellular acidiﬁcation rate (ECAR) was normalized to protein
content. L-lactate was measured by colorimetry (Abcam, #ab65331).
Microarray analyses. Total RNA from puriﬁed CD14+ monocytes was extracted
using the MagJET RNA puriﬁcation kit (Thermo Fisher Scientiﬁc). RNA was
quantiﬁed using NanoDrop™ 1000 spectrophotometer, and its integrity was
determined using the Agilent 2100 Bioanalyzer. Samples were hybridized onto an
Illumina HumanHT-12 v4 Expression BeadChip and scanned with an Illumina
iScan System (Illumina, San Diego, CA, USA). Data were analyzed using R. Data
was preprocessed by quantile normalization and log2 transformation. Probes that
were non-expressed (based on their detection p-values) were removed. For dif-
ferential gene analyses, linear models were ﬁt using limma64. Probes with FDR ≤
0.05 were considered differentially expressed.
For ClueGO pathway analyses, genes that were differentially expressed by
twofold or more when compared to adult or term samples were included. p-values
were adjusted for multiple comparisons using the Bonferonni step-down method.
GO biological-processes ontology was used. Degree of functional enrichment was
determined by sorting enriched terms based on a p-value threshold of <0.001. We
used GO tree intervals between levels 3 and 8 and Kappa Score Threshold of 0.04.
Gene Ontology analysis and Network images were generated using the ClueGO
2.3.3 plugin65 for Cytoscape 3.5.166. Heatmaps for metabolic pathways were
generated based on KEGG pathways.
Statistical analysis. For each experiment, sample size was estimated based on the
variance from 3 to 5 replicates in any age group (assuming comparable variance
between age groups). To avoid a selection bias, we balanced distribution of adult,
term, and preterm samples in batch experiments over time. GraphPad Prism v6.07
was used for graphs and statistical analyses. To simplify the ﬁgures, we present p
values only when indicated by the data. Differences between groups were analyzed
using 2-tailed t-tests, ANOVA (for groups) or as otherwise speciﬁed. Normality of
data was assumed in most statistical testing, unless grossly skewed. Statistical
signiﬁcance was considered at p values of <0.05. When data is shown in boxes and
whiskers, boxes are spanning from the ﬁrst quartile to the third quartile, with the
center line depicting the median. Whiskers are extending to the highest and lowest
points.
Data availability
Microarray data used in Figs. 3, 4a–c, 7h, Supplementary Data 1, 2 and 3, and
Supplementary Figures 3, 4, 5, 9 10A and 11 have been deposited in GEO under
accession code GSE104510. All other data, including raw data used in each ﬁgure
will be provided upon reasonable request to the corresponding author, and pro-
vided that the nature of the request complies with our institutional ethics board
policy.
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